ctDNA 'Unreliable' for Detecting CRC Recurrence After Surgery
Although circulating tumor DNA (ctDNA) tests are already marketed for this use, they provide no advantage over standard approaches, concludes a new review.
Medscape Medical News
source https://www.medscape.com/viewarticle/970601?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/970601?src=rss
Comments
Post a Comment